(Corrects LightInTheBox item to delete reference to company's quarterly results. The company did not report results, it only gave a revenue forecast.) (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
U.S. stock index futures were inching higher on Friday after major indexes suffered their biggest drop since July, ahead of data on economic growth and consumer optimism.
Dow Jones industrial average futures were up 0.04 percent at 16,907, S&P 500 futures were down 0.17 percent at 1,958.25 and Nasdaq 100 futures were up 0.01 percent at 4,008.
** JANUS CAPITAL GROUP INC, Thursday close $11.11, +38.52 pct premarket
Bill Gross, one of the bond market’s most renowned investors, is leaving Pimco, the asset management firm he founded, for rival asset management firm Janus Capital.
Shares of German insurer Allianz SE, the parent of Pimco, slumped 5.5 percent.
** DIGITAL ALLY, Thursday close $15.08, +18.10 pct premarket
The wearable video camera maker received an initial order worth about $200,000 from the U.S. military for complete video evidence gathering system. The company expects follow-on orders, it said.
** LIGHTINTHEBOX HOLDING CO LTD, Thursday close $5.72, +6.00 pct premarket
The online retailer raised its third-quarter revenue forecast.
** PULSE ELECTRONICS CORP, Thursday close $2.26, -11.50 pct premarket
The electronics components maker said it would delist from the New York Stock Exchange to save costs, giving it greater operational efficiencies.
** BLACKBERRY LTD, Thursday close $9.8, -2.35 pct premarket
The Canadian smartphone maker said second-quarter revenue fell nearly 42 percent to $916 million, missing the average analyst estimate of $949.63 million.
The stock had earlier risen about 4 percent after the company said its loss narrowed to $207 million from $965 million a year earlier in early sign turnaround efforts may be working.
** ACELRX PHARMACEUTICALS INC, Thursday close $6.72, -15.18 pct premarket
The U.S. FDA said it would take another six months to review a marketing application on the drugmaker’s recently rejected pain management device.
** REPROS THERAPEUTICS INC, Thursday close $8.96, +10.83 pct premarket
The drug developer said its experimental drug to treat low testosterone, Androxal, met the main goal of late-stage study.
The U.S FDA has granted the company a pre-drug approval meeting to discuss Androxal in the first half of November.
** SEADRILL LTD, Thursday close $26.97, -1.89 pct premarket
Analysts at Goldman Sachs downgraded the company’s Oslo-listed stock to “sell” from “neutral” saying deteriorating rig market and high level of financial leverage would likely prompt the company to cut dividend in 2016.
The world’s biggest offshore driller said earlier this month it expected the rig market to remain soft for next couple of years.
** AGIOS PHARMACEUTICALS INC, Thursday close $53.45, +7.15 pct premarket
The drug developer said it would present early-stage data on its experimental blood cancer drug AG-120 at a symposium in November.
According to a deal signed in 2010, Celgene has the option to develop any drugs resulting from the Agios' cancer metabolism research platform (link: reut.rs/1Bg2xG8)
Agios opted to retain the right to develop AG-120 in the U.S. on Feb. 3, while Celgene holds the right to develop the drug outside U.S.
** DIAMOND FOODS INC, Thursday close $26.62, +4.43 pct premarket
The packaged food company reported better-than-expected quarterly adjusted profit and sales, helped by higher demand for snacks such as Pop Secret popcorn and Kettle potato chips.
** MICRON TECHNOLOGY INC, Thursday close $31.7, +6.97 pct premarket
The memory chipmaker posted fiscal fourth-quarter results and gave a revenue outlook that impressed Wall Street as signs of stabilization in the personal computer industry supported demand for DRAM chips.
At least ten brokerages including Stifel Nicolaus and Raymond James raised their price targets on the stock.
** NIKE INC, Thursday close $79.75, +9.47 pct premarket
The world’s largest sportswear maker reported a better-than-expected quarterly profit as it gains market share in Europe and focuses on higher-margin products such as Flyknit soccer boots.
Janney Capital Markets upgraded the stock to “buy” from “neutral” and at least 13 brokerages raised their price target.
** FINISH LINE INC, Thursday close $29.41, -9.83 pct premarket
The footwear retailer posted a quarterly profit that missed Wall Street’s estimate, hurt by lower demand for basketball sporting goods. Its merchandise inventory increases 11.5 percent.
** ALIBABA GROUP HOLDING LTD, Thursday close $88.92, +0.85 pct premarket
The newest way to bet on the fortunes of Chinese e-commerce heavyweight Alibaba will debut on Monday when its stock options go live for trading, and investors should look for the initial action to be very busy, but also choppy and potentially pricey. Options market traders say Alibaba puts and calls will likely see heavy demand given the interest shown so far in the stock since its record-setting $25 billion IPO last week.
** INTEL CORP Thursday close $34.14, +0.32 pct premarket
Intel said it will pay as much as $1.5 billion for a 20 percent stake in two mobile chipmakers with ties to the Chinese government, in the hopes of catching up in a smartphone chip industry dominated by rival Qualcomm Inc.
** APPLE INC, Thursday close $97.87, +0.82 pct premarket
Apple broke its silence on complaints about bending iPhones, hours after withdrawing a glitch-ridden software update as the company struggles to restore momentum to the rollout of its latest phones.
** ASTRAZENECA, Thursday close $70.99, +0.82 pct premarket
The British pharmaceutical company said an expanded use of its IRESSA treatment for lung cancer has been recommended for approval by European regulators. (Compiled by Shailaja Sharma in Bangalore; Editing by Savio D‘Souza)